GCTK - CIK 0001506983
The table below shows GlucoTrack, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$15.24M | -$12.49M | -$6.56M | -$3.73M | -$3.77M | -$3.50M |
| Capital expenditure | $96.00K | $104.00K | - | $1.00K | $5.00K | $53.00K |
| Investing cash flow | -$96.00K | -$104.00K | - | $1.00K | -$1.00K | -$53.00K |
| Dividends paid | - | - | - | - | - |
GlucoTrack, Inc. reported operating cash flow of -$15.24M for fiscal year 2025. That is down 22.0% from -$12.49M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.31M (FY 2016) to -$15.24M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $17.04M | $13.74M | $8.73M | - | - | $13.01M |